The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global isothermal nucleic acid amplification technology market reached a value of US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2027, exhibiting at a CAGR of 12.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The isothermal nucleic acid amplification technology (INAAT) is used in the field of molecular biology and recombinant DNA technologies for detecting and analyzing nucleic acids. This technique is commonly used for DNA, RNA, cells, proteins, small molecules and ions to ensure the rapid, sensitive and accurate diagnosis of infectious, genetic and inherited diseases. The amplicons generated from this technique are used for producing versatile nucleic acid nanomaterials that are widely utilized in biomedicine, bioimaging and biosensing. They are also used for the detection of various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia and gonorrhea (CT/NG).
One of the leading trends in the global market is the ongoing development of INAAT for the detection of the coronavirus disease (COVID-19), as it can be conducted at room temperature, without the need for specialized laboratory equipment. Furthermore, the increasing prevalence of cancer and other chronic medical ailments, along with the rising demand for efficient diagnosis and treatment alternatives, is also providing a boost to the market growth. In line with this, the widespread adoption of Loop-mediated Isothermal Amplification (LAMP) tests that are used for the amplification of both DNA and RNA, along with the identification of genetically modified organisms (GMOs) is driving the product demand further. Additionally, various technological advancements, such as the development of Strand Displacement Amplification (SDA), Single Primer Isothermal Amplification (SPIA) and Recombinase Polymerase Amplification (RPA), is acting as another growth-inducing factor. Other factors, including the rising geriatric population across the globe, coupled with extensive research and development (R&D) activities in the field of microbiology and significant growth in the healthcare infrastructure, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end-user.
Breakup by Product:
Breakup by Technology:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, bioMérieux, BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG and Ustar Biotechnologies Ltd., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Technology, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, bioMérieux, BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG and Ustar Biotechnologies Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at